Innoviva Inc INVA Financial and Strategic SWOT Analysis Review [Report Updated: 25072017] Prices from USD $125

07:53 EDT 1 Aug 2017 | BioPortfolio Reports

Innoviva Inc INVA Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.
Corporate strategy Analyst's summarization of the company's business strategy.
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Innoviva Inc Innoviva, formerly Advanced Medicine Inc is a developer and commercializer of small molecule medicines. The company offers solutions for the improvement of patient care through companies that provides therapies. It develops products for various therapeutic areas such as respiratory disease, bacterial infections, and central nervous system. Innoviva's pipeline products include relvar and breo ellipta, and anoro ellipta. The company's programs include fluticasone furoate and vilanterol, umeclidinium and bifunctional muscarinic antagonistbeta2 agonist. Its other activities include product development, commercialization, and financial strategy. The company discovers medicines in areas of unmet medical need. It operates through pharma companies and other related organizations to develop its products. Innoviva is headquartered in Brisbane, California, the US.

Innoviva Inc Key Recent Developments

Jul 26,2017: Innoviva Reports Strong Second Quarter 2017 Financial Results
Apr 27,2017: Innoviva Reports First Quarter 2017 Financial Results
Apr 13,2017: Innoviva to Undertake Comprehensive Review of its Cost and Executive Compensation Structures
Feb 09,2017: Innoviva Reports Fourth Quarter and Full Year 2016 Financial Results
Oct 27,2016: Innoviva Reports Third Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Innoviva Inc INVA Financial and Strategic SWOT Analysis Review [Report Updated: 25072017] Prices from USD $125


More From BioPortfolio on "Innoviva Inc INVA Financial and Strategic SWOT Analysis Review [Report Updated: 25072017] Prices from USD $125"

Quick Search

Relevant Topic

Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...